0001140361-18-005581.txt : 20180207
0001140361-18-005581.hdr.sgml : 20180207
20180207160626
ACCESSION NUMBER: 0001140361-18-005581
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180207
FILED AS OF DATE: 20180207
DATE AS OF CHANGE: 20180207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'SILVA DHIREN
CENTRAL INDEX KEY: 0001662486
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 18581165
MAIL ADDRESS:
STREET 1: 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
doc1.xml
FORM 4
X0306
4
2018-02-07
1
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001662486
D'SILVA DHIREN
BLOCK 10-1, BLANCHARDSTOWN
CORPORATE PARK, BALLYCOOLIN
DUBLIN
L2
15
IRELAND
0
1
0
0
VP Irish & European Operations
ADSs
15000
D
Stock Option (right to buy)
23.53
2025-09-15
ADSs
50000
50000
D
Stock Option (right to buy)
10.4
2026-12-14
ADSs
80000
80000
D
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs are represented by American Depositary Receipts.
Represents 15,000 restricted ADSs granted under the issuer's "Free Share" award program on 12/14/2016, all of which will be issued to the reporting person on the second anniversary of the grant date.
Options become exercisable as to 12,500 ADSs on each of the first four anniversaries after the 09/15/2015 grant date.
Options become exercisable as to 20,000 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
This filing constitutes a Form 4 exit filing for the Reporting Person as the Reporting Person is no longer subject to Section 16 under the Securities Exchange Act of 1934.
/s/ Phillandas T. Thompson, as attorney-in-fact for Dhiren D'Silva
2018-02-07